Gelstat Corp - Understand $gsac stock

$GSAC Market Cap: $247.2 Thousand

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$1.681M

TTM

Gross Margin

43.74%

TTM

Net Earnings

-$1.222M

TTM

Current Assets

$920.1K

Q2 2015

Current Liabilities

$1.609M

Q2 2015

Current Ratio

57.18%

Q2 2015

Total Assets

$7.102M

Q2 2015

Total Liabilities

$1.684M

Q2 2015

Book Value

$5.417M

Q2 2015

Cash

$7.760K

Q2 2015

P/E

-0.2024

Nov 14, 2024 EST

Free Cash Flow

$63.27K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$2.330K	$7.020K	$3.950K	$1.313M	$15.89K	$21.45K	$61.75K	$23.02K	$18.18K	$230.0K	$340.0K	$250.0K	$0.00	$0.00
YoY Change	-66.81%	77.72%		8161.04%	-25.92%		168.25%	26.62%	-92.1%	-32.35%	36.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	$2.330K	$7.020K	$3.950K	$1.313M	$15.89K	$21.45K	$61.75K	$23.02K	$18.18K	$230.0K	$340.0K	$250.0K	$0.00	$0.00
Cost Of Revenue	$1.370K	$3.020K	$1.410K	$1.091M	$12.40K	$9.180K	$17.31K	$1.700K	$5.100K	$90.00K	$350.0K	$570.0K	$0.00	$0.00
Gross Profit	$960.00	$4.000K	$2.540K	$221.9K	$3.490K	$12.27K	$44.44K	$21.32K	$13.08K	$150.0K	-$20.00K	-$320.0K	$0.00	$0.00
Gross Profit Margin	41.2%	56.98%	64.3%	16.9%	21.96%	57.2%	71.97%	92.62%	71.95%	65.22%	-5.88%	-128.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Selling, General & Admin	$528.0K	$317.3K	$180.1K	$1.524M	$413.3K	$416.9K	$79.83K	$439.1K	$1.053M	$1.870M	$3.630M	$5.390M	$1.320M	$130.0K
YoY Change	66.4%	76.21%		268.78%	-0.87%		-81.82%	-58.31%	-43.67%	-48.48%	-32.65%	308.33%	915.38%
% of Gross Profit	55000.0%	7932.75%	7089.76%	687.0%	11842.41%	3397.88%	179.64%	2059.66%	8052.75%	1246.67%
Research & Development									$0.00	$40.00K	$70.00K	$170.0K	$160.0K	$20.00K
YoY Change									-100.0%	-42.86%	-58.82%	6.25%	700.0%
% of Gross Profit									0.0%	26.67%
Depreciation & Amortization				$57.88K	$1.420K	$1.290K			$970.00	$0.00	$60.00K	$20.00K	$0.00	$0.00
YoY Change				3976.06%	10.08%					-100.0%	200.0%
% of Gross Profit				26.09%	40.69%	10.51%			7.42%	0.0%
Operating Expenses	$529.0K	$317.3K	$180.1K	$1.524M	$413.3K	$416.9K	$79.83K	$439.1K	$1.053M	$1.910M	$3.700M	$5.540M	$1.480M	$150.0K
YoY Change	66.71%	76.2%		268.78%	-0.87%		-81.82%	-58.31%	-44.85%	-48.38%	-33.21%	274.32%	886.67%
Operating Profit	-$528.0K	-$313.3K	-$177.6K	-$1.302M	-$409.8K	-$404.6K	-$35.39K	-$417.8K	-$1.040M	-$1.760M	-$3.720M	-$5.860M	-$1.480M	-$150.0K
YoY Change	68.53%	76.47%		217.78%	1.28%		-91.53%	-59.84%	-40.9%	-52.69%	-36.52%	295.95%	886.67%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Interest Expense	-$165.5K	-$230.4K	-$2.290K	-$3.890K	$0.00		-$4.660K	-$45.26K	-$43.24K	-$60.00K	-$250.0K	-$180.0K	$0.00	$0.00
YoY Change	-28.18%	9959.83%					-89.7%	4.67%	-27.93%	-76.0%	38.89%
% of Operating Profit
Other Income/Expense, Net				$8.680K	$2.420K	$868.8K	$0.00					$0.00
YoY Change				258.68%	-99.72%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Pretax Income	-$761.2K	-$475.2K	-$177.8K	-$1.298M	-$407.4K	$464.1K	-$81.61K	-$463.1K	-$1.083M	-$1.820M	-$5.760M	-$6.220M	-$1.470M	-$150.0K
YoY Change	60.17%	167.23%		218.5%	-187.78%		-82.38%	-57.26%	-40.47%	-68.4%	-7.4%	323.13%	880.0%
Income Tax				$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income						0.0%
Net Earnings	-$761.2K	-$475.2K	-$177.8K	-$1.298M	-$407.4K	$464.1K	-$81.61K	-$463.1K	-$1.083M	-$1.820M	-$5.790M	-$6.220M	-$1.470M	-$150.0K
YoY Change	60.17%	167.23%		218.5%	-187.78%		-82.38%	-57.26%	-40.47%	-68.57%	-6.91%	323.13%	880.0%
Net Earnings / Revenue	-32669.1%	-6769.8%	-4502.28%	-98.85%	-2563.81%	2163.64%	-132.16%	-2011.56%	-5959.68%	-791.3%	-1702.94%	-2488.0%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	$0.00	-$3.812K	-$2.761K	$3.428K	-$2.331K	-$15.14K	-$43.39K	-$99.18K	-$405.5K	-$561.9K	-$216.8K	-$38.96K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Cash & Short-Term Investments	$1.730K	$67.14K	$770.00	$96.68K	$95.08K	$1.010K	$220.00	$820.00	$1.160K	$10.00K	$230.0K	$170.0K	$420.0K	$130.0K
YoY Change	-97.42%	8619.48%		1.68%	9313.86%		-73.17%	-29.31%	-88.4%	-95.65%	35.29%	-59.52%	223.08%
Cash & Equivalents				$96.68K	$95.08K	$1.010K	$220.00	$820.00	$1.160K	$10.00K	$230.0K	$170.0K	$420.0K	$130.0K
Short-Term Investments
Other Short-Term Assets				$153.7K	$39.09K	$0.00	$0.00	$20.00K	$25.00K	$20.00K	$60.00K	$380.0K	$520.0K	$10.00K
YoY Change				293.12%			-100.0%	-20.0%	25.0%	-66.67%	-84.21%	-26.92%	5100.0%
Inventory	$0.00	$75.06K	$75.26K	$451.4K	$98.74K	$78.97K	$222.2K				$0.00	$1.310M	$0.00
Prepaid Expenses
Receivables	$80.00	$90.00	$30.00	$113.1K	$0.00		$21.57K	$0.00	$49.20K	$120.0K	$130.0K	$210.0K	$0.00
Other Receivables	$2.300K	$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$270.0K	$0.00
Total Short-Term Assets	$4.110K	$142.3K	$76.06K	$814.8K	$232.9K	$79.98K	$244.0K	$20.82K	$75.36K	$150.0K	$420.0K	$2.340M	$940.0K	$140.0K
YoY Change	-97.11%	87.08%		249.87%	191.2%		1071.81%	-72.37%	-49.76%	-64.29%	-82.05%	148.94%	571.43%
Property, Plant & Equipment	$12.72K	$37.80K	$62.16K	$145.7K	$2.600K	$0.00	$5.000K				$0.00	$110.0K	$210.0K	$0.00
YoY Change	-66.35%	-39.19%		5503.85%							-100.0%	-47.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments							$0.00					$0.00
YoY Change
Other Assets	$2.000K	$2.000K	$2.000K	$24.67K	$9.100K	$2.500K	$0.00	$2.500K	$2.500K	$0.00	$10.00K	$10.00K	$30.00K	$0.00
YoY Change	0.0%	0.0%		171.1%	264.0%		-100.0%	0.0%		-100.0%	0.0%	-66.67%
Total Long-Term Assets	$14.72K	$39.80K	$64.16K	$6.235M	$2.885M	$20.87K	$5.000K	$26.02K	$27.31K	$20.00K	$20.00K	$220.0K	$290.0K	$20.00K
YoY Change	-63.02%	-37.97%		116.08%	13725.4%		-80.78%	-4.72%	36.55%	0.0%	-90.91%	-24.14%	1350.0%
Total Assets	$18.83K	$182.1K	$140.2K	$7.049M	$3.118M	$100.9K	$249.0K	$46.84K	$102.7K	$170.0K	$440.0K	$2.560M	$1.230M	$160.0K
YoY Change
Accounts Payable	$76.00K	$55.55K	$51.57K	$791.7K	$209.7K	$215.6K	$665.9K	$1.126M	$1.020M	$790.0K	$710.0K	$450.0K	$130.0K	$0.00
YoY Change	36.81%	7.72%		277.44%	-2.7%		-40.84%	10.38%	29.08%	11.27%	57.78%	246.15%
Accrued Expenses	$272.5K	$208.8K	$115.8K				$6.380K	$421.4K	$376.2K	$330.0K	$300.0K	$380.0K	$120.0K	$0.00
YoY Change	30.49%	80.29%					-98.49%	12.03%	13.99%	10.0%	-21.05%	216.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$168.3K	$84.85K	$17.20K	$0.00		$533.0K	$569.5K	$558.0K	$540.0K	$540.0K	$290.0K	$0.00	$300.0K
YoY Change	-100.0%	98.35%					-6.42%	2.07%	3.34%	0.0%	86.21%		-100.0%
Long-Term Debt Due	$89.21K
YoY Change
Total Short-Term Liabilities	$462.9K	$498.3K	$306.2K	$1.374M	$209.7K	$215.6K	$1.205M	$2.232M	$2.069M	$1.770M	$1.660M	$1.110M	$250.0K	$310.0K
YoY Change	-7.12%	62.78%		554.93%	-2.7%		-46.0%	7.86%	16.9%	6.63%	49.55%	344.0%	-19.35%
Long-Term Debt	$261.2K	$0.00	$0.00	$0.00	$0.00			$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$12.72K	$37.80K			$0.00						$0.00	$50.00K	$0.00
YoY Change	-100.0%	-66.35%										-100.0%
Total Long-Term Liabilities	$261.2K	$12.72K	$37.80K	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$50.00K	$0.00
YoY Change	1953.77%	-66.35%										-100.0%
Total Liabilities	$724.1K	$511.1K	$344.0K	$1.374M	$209.7K	$215.6K	$1.205M	$2.232M	$2.069M	$1.770M	$1.660M	$1.110M	$300.0K	$310.0K
YoY Change	41.68%	48.59%		554.93%	-2.7%		-46.0%	7.86%	16.9%	6.63%	49.55%	270.0%	-3.23%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2022	2021	2020	2014	2013	2012	2009	2008	2007	2006	2005	2004	2003	2002
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $247.19 Thousand

About Gelstat Corp

GelStat Corp. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Miami, Florida and currently employs 0 full-time employees. The firm's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security. The firm has acquired the intellectual property of Duos Technologies Group, Inc.

Industry: Pharmaceutical Preparations Peers: Kaya Holdings Inc Baudax Bio, Inc. Bespoke Extracts Inc Clarus Therapeutics Holdings, Inc. Earth Science Tech Inc Innovation1 Biotech Inc. Johnson & Johnson NEUROPATHIX, INC.